Clinical trials: Intravenous Injections

HIV Infections, Depression

Cognitive Behavioral Therapy Combined With Antidepressants to Reduce HIV Risk and Drug Relapse Among Depressed Intravenous Drug Users

• Completed
• Age: 18 to 75 years
• Phase 3
• Lifestyle or therapy programme

This study will evaluate the effectiveness of combining cognitive behavioral therapy (CBT) and antidepressants in reducing HIV risk behavior and drug relapse rates in depressed intravenous drug users.

Conditions

HIV Infections, Depression, Substance-Related Disorders

Trial name

NCT00183768

Testing

Cognitive Behavioral Therapy, Psychopharmacology

Where

United States

Volunteers

175 people

Sponsor

Butler Hospital